Thermo Fischer Scientific Reports the Launch of the First-Ever GMP- and Cleanroom-Compatible CO2 Incubator
Featuring a robust stainless-steel exterior and IP54-compliant design, the Vios CR CO2 incubator can withstand the rigorous and repeated cleaning procedures that are integral to effective cleanroom management, enabling long-term use and maximum return on investment.
Thermo Fisher Scientific Launches CE-IVD-Marked High Throughput COVID-19 Diagnostic Solution Using Automated Amplitude Platform
The high-throughput solution enables clinical and public health laboratories to efficiently test up to 8,000 COVID-19 samples a day with fewer staffing requirements and a reliable supply of kits, reagents and consumables.
ImmunoCAP Specific IgE alpha-Gal Allergen Component Test is the most widely used specific IgE blood test, and its use is documented in more than 6,000 peer-reviewed publications.
The Ion Torrent CarrierSeq ECS Kit for the Ion GeneStudio S5 System consolidates a multi-platform approach to expanded carrier screening into a single solution that extends the company's reproductive health research portfolio, which includes tools for prenatal, postnatal, in-vitro fertilization and newborn screening analysis.
Thermo Fisher Scientific Expands Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories
The portfolio enables clinical diagnostic laboratories to leverage a comprehensive platform for developing sensitive and reliable laboratory developed tests.
New Thermo Scientific Scientific HAAKE MARS iQ Rheometer Series Is Designed for Quality Control Labs
Key features such as touchscreen control that allows users to quickly execute standard operating procedures (SOPs) and intuitive "Connect Assist" functionalities mean QC lab technicians can deliver more consistent and reliable results, even in busy labs with multiple operators running tests.
FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies Notes Thermo Fisher Scientific
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific for the first next-generation sequencing (NGS)-based test that simultaneously screens tumor samples for biomarkers associated with three FDA-approved therapies for non-small cell...